-
公开(公告)号:USRE44459E1
公开(公告)日:2013-08-27
申请号:US13410973
申请日:2012-03-02
摘要: The invention disclosed comprises a method for administering the antidiabetic drug glipizide to a patient in need of glipizide in need of antidiabetic therapy.
-
公开(公告)号:US08084059B2
公开(公告)日:2011-12-27
申请号:US11522014
申请日:2006-09-15
CPC分类号: A61K31/135 , A61K9/0004 , Y10S514/96 , Y10S514/964
摘要: The invention pertains to a dosage form 10 and to administering an antidepressant medicament 16 for an extended period of time in a rate-known dose.
摘要翻译: 本发明涉及一种剂型10,并以剂量已知的剂量给予抗抑郁药物16延长一段时间。
-
公开(公告)号:US07803401B2
公开(公告)日:2010-09-28
申请号:US11589558
申请日:2006-10-30
CPC分类号: A61K9/4858 , A61K9/0004 , A61K9/1075 , A61K9/4866
摘要: A sustained release dosage form includes a capsule made of a thermoplastic polymer having a softening point below 200° C. and an orifice formed or formable within the capsule, an emulsion formulation contained within the capsule, and an expandable composition within the capsule remote from the orifice. The emulsion formulation comprises a drug, an emulsifying surfactant, and an oil. The expandable composition is configured to expand and expel the emulsion formulation through the orifice.
摘要翻译: 持续释放剂型包括由软化点低于200℃的热塑性聚合物制成的胶囊,以及在胶囊内形成或可形成的孔,包含在胶囊内的乳剂,以及远离胶囊内的胶囊内的可膨胀组合物 孔。 乳液制剂包含药物,乳化表面活性剂和油。 可膨胀组合物构造成通过孔膨胀和排出乳液制剂。
-
公开(公告)号:US5869096A
公开(公告)日:1999-02-09
申请号:US353568
申请日:1994-12-09
CPC分类号: A61K9/0004
摘要: An osmotic device (10) for delivering a beneficial drug, such as an anti-fungal, into the mouth of a human patient is disclosed. The device (10) has a size and shape adapting it to be comfortably retained in the mouth for extended periods of time. The device (10) comprises a wall (12) surrounding a compartment (13) housing a layer of an agent (14) that is insoluble to very soluble in aqueous biological fluids, e.g., saliva, and a layer (16) of a fluid swellable, hydrophilic polymer. A passageway (17) in the wall (12) connects the agent (14) with the exterior of the device (10). The wall (12) is permeable to the passage of aqueous biological fluid but substantially impermeable to the passage of the hydrophilic polymer (16). In one embodiment the beneficial agent (14) has a different color than the hydrophilic polymer (16). The wall (12) is sufficiently translucent to permit the patient to see the amount of drug/beneficial agent (14) remaining to be delivered. Marking lines (19) may be provided on the wall (12) indicating the amount of drug/agent (14) which has been delivered and/or the amount remaining to be delivered.
摘要翻译: 公开了一种用于将有益药物(例如抗真菌)递送到人类患者的口中的渗透装置(10)。 装置(10)具有适应其舒适地保持在口中长时间的尺寸和形状。 装置(10)包括围绕隔室(13)的壁(12),该隔室(13)容纳不溶于非常可溶于水生物流体(例如唾液)的试剂(14)层,以及流体层 可溶胀的亲水性聚合物。 壁(12)中的通道(17)将试剂(14)与装置(10)的外部连接。 所述壁(12)对于水性生物流体的通道是可渗透的,但是对于亲水性聚合物(16)的通过基本上是不透水的。 在一个实施方案中,有益剂(14)具有与亲水性聚合物(16)不同的颜色。 壁(12)是足够半透明的,以允许患者看到待传送的药物/有益剂(14)的量。 标记线(19)可以设置在壁(12)上,指示已经被输送的药物/试剂(14)的量和/或剩余的待传送量。
-
公开(公告)号:US5614578A
公开(公告)日:1997-03-25
申请号:US330892
申请日:1994-10-28
IPC分类号: A61K9/00 , A61K9/20 , A61K47/34 , A61K47/38 , B01D71/48 , C08L1/28 , C08L67/04 , C08L71/02 , C08K5/06
CPC分类号: C08L67/04 , A61K47/34 , A61K47/38 , A61K9/0004 , A61K9/2095 , B01D71/48 , C08L71/02 , C08L1/284
摘要: A dosage form is disclosed comprising an injection-molded housing member free of organic solvents.
摘要翻译: 公开了一种剂型,其包括不含有机溶剂的注塑外壳构件。
-
公开(公告)号:US5413572A
公开(公告)日:1995-05-09
申请号:US203135
申请日:1994-02-18
IPC分类号: A61K20060101 , A61K9/00 , A61K9/22 , A61K9/52 , A61K9/66
CPC分类号: A61K9/0004
摘要: An osmotic system is disclosed for delivering a beneficial agent formulation to an environment of use. The osmotic system comprises (a) an outside semipermeable wall, (b) a middle osmotically active layer, (c) a capsule comprising a beneficial agent, and (d) a passageway for dispensing the beneficial agent from the osmotic system.
摘要翻译: 公开了用于将有益剂制剂递送到使用环境的渗透系统。 渗透系统包括(a)外部半透壁,(b)中间渗透活性层,(c)包含有益剂的胶囊,和(d)用于从渗透系统分配有益剂的通道。
-
公开(公告)号:US5254349A
公开(公告)日:1993-10-19
申请号:US963962
申请日:1992-10-21
申请人: Liang C. Dong , Michael H. Dealey , Terry L. Burkoth , Patrick S. L. Wong , Jerry D. Childers , Brian L. Barclay
发明人: Liang C. Dong , Michael H. Dealey , Terry L. Burkoth , Patrick S. L. Wong , Jerry D. Childers , Brian L. Barclay
CPC分类号: A61K9/0004
摘要: A dosage form is disclosed comprising means for lessening the tackiness and/or irritation of the components of the dosage form to mucosal tissue. The dosage form provides means for forming in the dosage form a floc comprising a drug, which floc, when delivered from the dosage form, lessens the tackiness and/or irritation of the mucosal tissue of a warm-blooded recipient.
摘要翻译: 公开了一种剂型,其包括用于减轻剂型组分对粘膜组织的粘性和/或刺激性的方法。 剂型提供了用于在剂型中形成包含药物的絮凝物,当从剂型递送时,该絮凝剂减轻温血接受者的粘膜组织的粘性和/或刺激性。
-
公开(公告)号:US5147654A
公开(公告)日:1992-09-15
申请号:US793058
申请日:1991-11-15
IPC分类号: A61K9/00 , A61K31/465
CPC分类号: A61K31/465 , A61K9/0004
摘要: An osmotic device (10) for the controlled systemic delivery of nicotine through an oral mucosal membrane of a human patient is disclosed. The device (10) has a size and shape adapting it to be comfortably retained in the mouth for extended periods of time. The device (10) comprises a semipermeable wall (12) surrounding a compartment (13) containing a nicotine salt (14) and optionally an alkaline salt which is capable of reacting with the nicotine salt in the presence of water to form nicotine base. The conversion of nicotine salt to nicotine base may take place within the device (10) and/or outside the device and in the patient's mouth. Nicotine base and/or salt is delivered from the compartment (13) through a passageway (17) in the wall (12). The nicotine salt exhibits good stability and shelf life while the nicotine base exhibits excellent absorption through oral mucosal membranes.
摘要翻译: 公开了用于通过人类患者的口腔粘膜控制的尼古丁系统递送的渗透装置(10)。 装置(10)具有适应其舒适地保持在口中长时间的尺寸和形状。 装置(10)包括围绕含有尼古丁盐(14)和任选的碱性盐的隔室(13)的半透壁(12),其能够在水存在下与尼古丁盐反应以形成尼古丁碱。 尼古丁盐转化为尼古丁碱可以在装置(10)内和/或在装置外部和患者口中进行。 尼古丁碱和/或盐通过壁(12)中的通道(17)从隔室(13)输送。 尼古丁盐表现出良好的稳定性和保质期,而尼古丁碱通过口腔粘膜表现出优异的吸收。
-
公开(公告)号:US5141752A
公开(公告)日:1992-08-25
申请号:US715256
申请日:1991-07-25
申请人: Atul D. Ayer , Felix Theeuwes , Patrick S. L. Wong
发明人: Atul D. Ayer , Felix Theeuwes , Patrick S. L. Wong
CPC分类号: A61K9/0004
摘要: A dosage form comprising (1) an immediately available dose of a beneficial drug followed by a timed delayed dose of drug, or (2) a timed delayed dose of drug.
摘要翻译: 一种剂型,其包含(1)立即可用的有效药物剂量,然后是药物的定时延迟剂量,或(2)定时延迟剂量的药物。
-
公开(公告)号:US5082668A
公开(公告)日:1992-01-21
申请号:US595140
申请日:1990-10-09
CPC分类号: A61K9/0004
摘要: A device is disclosed comprising a wall that surrounds a compartment. The compartment comprises a beneficial agent composition and a push composition. A passageway in the wall connects the compartment with the exterior of the device for delivering the beneficial agent at a rate governed, in combination, by the wall, the beneficial agent composition and the push composition through the passageway of the device over time.
摘要翻译: 公开了一种包括围绕隔室的壁的装置。 隔室包含有益剂组合物和推组合物。 壁中的通道将隔室与装置的外部连接,用于通过墙壁,有益剂组合物和推动组合物通过装置的通道随时间而被组合地传递有益剂。
-
-
-
-
-
-
-
-
-